BOSTON and SEOUL, Korea, June 6, 2022 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON" or "Company") announced today that the company has successfully completed the GLP toxicology studies of BAL200. The ...
Confirmed antibacterial efficacy against a variety of anthrax strains including the one used in the 2001 anthrax attack Provides the most potent bactericidal ability that no other PEP antibiotics in ...
BOSTON and SEOUL, South Korea, July 2, 2025 /PRNewswire/ -- More than 1,200 reported cases of CRE (Carbapenem-Resistant Enterobacteriaceae) infections have been reported in the In-cheon region of ...
iNtRON stated that following the proprietary development of the Robot Bacteriophage 2 nd generation technology, additional in-vitro evolution technology was applied. The Company previously secured the ...
Intron Technology’s 01760 2022 result was driven by strong growth in revenue from electric vehicles and automated vehicles, with consolidated revenue up 52% and net profit up 107%. Together, these two ...
The MarketWatch News Department was not involved in the creation of this content. -- Gram-negative bacterial infections are becoming an increasingly serious global health issue -- U.S. patent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results